Document Detail


Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
MedLine Citation:
PMID:  8133793     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The transdermal and oral administration of estrogens for one year were compared with respect to the effects on lipid metabolism. Eighty-one postmenopausal women (1.5-3 years after menopause) were randomly divided into three groups. The first two groups received sequential estrogen treatment with either transdermal estradiol (Estraderm TTS, Ciba Geigy; 50 micrograms/day; 24 women) or 0.625 mg/day conjugated estrogens (Premarin, Wyeth; 20 subjects), respectively. In both groups medroxyprogesterone (10 mg/day per os) was added for 12 days of each cycle. Thirty-five subjects served as control group without therapy. No significant changes in the lipid profile was observed in control subjects after 1 year of follow-up. Serum triglycerides decreased significantly (-10.9 +/- 26% S.D.; P < 0.05) in transdermal treated women, whereas it slightly rose in oral estrogen group. Comparable significant decreases in total and low density lipoprotein (LDL) cholesterol (mean range -6.5/-18.0%) were observed in women on estrogen replacement therapy. High density lipoprotein (HDL) cholesterol significantly diminished in transdermal estradiol group, but it rose slightly in the oral estrogen group. Thus the fraction of HDL cholesterol over LDL cholesterol did not change in the transdermal group whereas it significantly rose in subjects treated with oral estrogens. It remains to be established to what extent these differences on lipid metabolism are relevant for the prevention of cardiovascular diseases.
Authors:
S Adami; M Rossini; N Zamberlan; F Bertoldo; R Dorizzi; V Lo Cascio
Related Documents :
3116293 - Serum lipoproteins in home total parenteral nutrition patients.
7449053 - Association of risk factor variables and coronary artery disease documented with angiog...
6704963 - Effect of dietary unsaturated and saturated fats on azoxymethane-induced colon carcinog...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Maturitas     Volume:  17     ISSN:  0378-5122     ISO Abbreviation:  Maturitas     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1994-04-19     Completed Date:  1994-04-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7807333     Medline TA:  Maturitas     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  191-6     Citation Subset:  IM    
Affiliation:
Istituto di Semeiotica e Nefrologia Medica, Università di Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Cutaneous
Administration, Oral
Cholesterol / blood
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Estradiol / administration & dosage
Estrogen Replacement Therapy* / methods
Estrogens, Conjugated (USP) / administration & dosage
Female
Humans
Lipids / blood*
Lipoproteins / blood*
Middle Aged
Postmenopause / blood*
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Estrogens, Conjugated (USP); 0/Lipids; 0/Lipoproteins; 0/Triglycerides; 50-28-2/Estradiol; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of spontaneous and surgical menopause on atherogenic metabolic risk.
Next Document:  Gynecologic complications of cyclic estrogen progestin therapy.